Despite setbacks and funding cuts — and a quieting of the hype blaring its arrival — multiple CRISPR-based trials are ...
Two recent studies identified gene knockouts that may make CAR T-cell therapy more effective, but the next step is applying the hypotheses in humans.
Preclinical data presented at the European Society of Gene and Cell Therapy (ESGCT) highlight a potential best-in-class profile--The AATD ...
CRISPR Therapeutics (CRSP) reported new preclinical data from its novel SyNTase gene editing platform for the treatment of Alpha-1 Antitrypsin ...
CRISPR Therapeutics has developed SyNTase editing ... off-target effects. In a humanized mouse model, SyNTase editing components encapsulated in a lipid nanoparticle (LNP) enabled highly efficient, ...
CRISPR Therapeutics (CRSP) announced the acceptance of an abstract for oral presentation at the European Society of Gene and Cell Therapy, ESGCT, ...
UC San Francisco scientists used CRISPRa to boost healthy SCN2A gene expression in mice, reducing seizures and restoring ...
Colorectal cancer (CRC) remains one of the most prevalent cancers worldwide and a leading cause of cancer mortality. Despite ...
An international research team led by Baylor College of Medicine and The University of Osaka have found a way to resume sperm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback